Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02046902 · ClinicalTrials.gov registry record
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
A clinical trial of Heart Diseases, sponsored by University of Missouri, Kansas City.
- Completed
- Registry status
- 586
- Enrollment target
- 2
- Study locations
NCT02046902 is a study of Heart Diseases that has completed, run by University of Missouri, Kansas City. The registered enrollment target is 586 participants, below the 5,525-participant average among 85 other Heart Diseases trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02046902, a study of Heart Diseases, has completed, sponsored by University of Missouri, Kansas City.
- COMPLETED
- Registry status
- 586 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to gather input from patients who have undergone PCI, their family and/or caregivers, and clinicians to develop a patient decision aid. The purpose of the decision aid is to deliver information, including individualized estimates of patients' restenosis risk, in an understandable format that would be informative and assist in decision-making for patients undergoing PCI.
Conditions Studied
Study Locations (2)
Missouri
- Truman Medical Center - Kansas City
- Saint Luke's Hospital of Kansas City - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 586 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02046902
The ClinicalTrials.gov registry entry for NCT02046902 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 586 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,525-participant average among 85 other Heart Diseases trials with a reported enrollment target (89% lower). The listed sponsor is University of Missouri, Kansas City, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT02046902 reports 2 study locations spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT02046902 about?
NCT02046902 is a clinical study titled "Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection". The goal of this study is to gather input from patients who have undergone PCI, their family and/or caregivers, and clinicians to develop a patient decision aid. The purpose of the decision aid is to deliver information, including individualized estimates of patients' restenosis risk, in an understa...
What is the current status of trial NCT02046902?
This trial is currently completed. The enrollment target is 586 participants. The study started on 2014-09. Estimated completion is 2016-12-31.
What conditions does trial NCT02046902 study?
This clinical trial studies the following conditions: Heart Diseases.
Who is sponsoring clinical trial NCT02046902?
This trial is sponsored by University of Missouri, Kansas City, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02046902 being conducted?
This trial has 2 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Angiography and Electrogram Guided Bachmann Bundle Pacing
RECRUITING · NA
-
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
RECRUITING · NA
-
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
Lumason® Infusion vs. Bolus Administrations
RECRUITING · Phase 3
-
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.